Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. (SHE:301584)
China · Delayed Price · Currency is CNY 18.53
+0.60 (3.35%)
At close: Sep 30, 2026
SHE:301584 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 19,437 | 19,430 | 17,923 | 15,443 | 11,882 | 10,024 |
Revenue Growth | 7.64% | 8.41% | 16.05% | 29.97% | 18.54% | 17.35% |
Gross Profit Gross Profit Growth | 1,487 | 1,486 | 1,321 | 1,179 | 896.48 | 685.03 |
Operating Income Operating Income Growth | 587.37 | 579.63 | 541.74 | 442.8 | 323.06 | 261.45 |
Net Income Net Income Growth | 285.6 | 269.63 | 228.31 | 196.3 | 174.28 | 166.94 |
Earnings Per Share EPS Growth | 0.71 | 0.71 | 0.64 | 0.55 | 0.49 | 0.47 |
EPS Growth | 10.50% | 10.94% | 16.36% | 12.25% | 4.25% | 4.44% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Direct Selling Business Direct Selling Business Growth | 11,053 | 11,032 | 10,056 | 7,797 | 7,511 |
Distribution Business Distribution Business Growth | 8,047 | 6,738 | 5,283 | 4,036 | 2,472 |
Service Business Service Business Growth | 285.38 | 112.39 | 75.47 | 33.24 | 24.66 |
Unallocated Other Unallocated Other Growth | 44.14 | 40.4 | - | - | - |
Total Total Growth | 19,430 | 17,923 | 15,414 | 11,867 | 10,008 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,598 | 1,927 | 1,788 | 1,487 | 1,051 | 577.97 |
Total Debt Total Debt Growth | 3,535 | 3,588 | 4,044 | 3,661 | 2,552 | 1,323 |
Net Cash (Debt) Net Cash Growth | -1,937 | -1,661 | -2,256 | -2,174 | -1,501 | -744.9 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -4.84 | -4.37 | -6.32 | -6.09 | -4.22 | -2.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,021 | 748.31 | 164.48 | -374.57 | -627.89 | -732.97 |
Capital Expenditures CapEx Growth | -74.2 | -80.71 | -121.05 | -82.39 | -33.5 | -10.18 |
Free Cash Flow Free Cash Flow Growth | 947.04 | 667.6 | 43.42 | -456.96 | -661.39 | -743.15 |
Free Cash Flow Growth | - | 1437.49% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 7.65% | 7.65% | 7.37% | 7.64% | 7.54% | 6.83% |
Operating Margin | 3.02% | 2.98% | 3.02% | 2.87% | 2.72% | 2.61% |
Pretax Margin | 2.50% | 2.32% | 2.11% | 2.04% | 2.10% | 2.30% |
Profit Margin | 1.47% | 1.39% | 1.27% | 1.27% | 1.47% | 1.67% |
FCF Margin | 4.87% | 3.44% | 0.24% | -2.96% | -5.57% | -7.41% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 1.08% | 0.69% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.99 | 45.66 | - | - | - | - |
P/FCF Ratio | 8.24 | 18.44 | - | - | - | - |
PS Ratio | 0.40 | 0.63 | - | - | - | - |